Related Experiment Video
Updated: Aug 7, 2026

Automating Tumor Implantation in Zebrafish Larvae for Cancer Research and Medicine
Published on: September 19, 2025
Fra-1 a target for cancer prevention or intervention
Matthew R Young1, Nancy H Colburn
1Laboratory of Cancer Prevention, National Cancer Institute-Frederick, Frederick, MD 21702, USA. youngm@ncifcrf.gov
Abstract:
The transcription factor activator protein-1 (AP-1) has been implicated as a driver of carcinogenesis since its original characterization. Oncogenic transcription factors like AP-1 are becoming new targets for cancer intervention. Inhibitors of AP-1 have been shown to block tumor promotion, transformation, progression and invasion. The Fos related antigen-1 (Fra-1) is activated in multiple cancers and gene ablation can suppress the invasive phenotypes of many tumor cell lines. This review focuses on the regulation of fosl1 expression, stabilization and activation of the Fra-1 polypeptide and on Fra-1-mediated tumorigenesis.
Insights
Activator protein-1 (AP-1), a cancer-driving transcription factor, and its component Fos related antigen-1 (Fra-1) are key targets for cancer intervention. Inhibiting Fra-1 suppresses tumor growth and invasion.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- The transcription factor activator protein-1 (AP-1) is recognized as a significant driver of carcinogenesis.
- Oncogenic transcription factors, including AP-1, represent emerging therapeutic targets for cancer intervention.
- AP-1 inhibitors have demonstrated efficacy in blocking tumor promotion, transformation, progression, and invasion.
Purpose of the Study:
- To review the regulation of Fos related antigen-1 (Fra-1) expression.
- To examine the stabilization and activation mechanisms of the Fra-1 polypeptide.
- To elucidate the role of Fra-1 in mediating tumorigenesis.
Main Methods:
- Literature review focusing on AP-1 and Fra-1.
- Analysis of studies on gene regulation and protein stabilization.
- Examination of research on Fra-1's role in cancer phenotypes.
Main Results:
- Fra-1 is frequently activated across various cancer types.
- Ablation of Fra-1 gene expression can significantly suppress the invasive characteristics of numerous tumor cell lines.
- Understanding Fra-1's regulatory pathways is crucial for developing targeted therapies.
Conclusions:
- Fra-1 is a critical mediator of tumorigenesis and cancer cell invasion.
- Targeting Fra-1 presents a promising strategy for novel cancer therapeutics.
- Further research into Fra-1's molecular mechanisms can lead to improved cancer treatments.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer
Preventive Healthcare Services

